UNITY Biotechnology, Inc. (UBX) Prices 5M Share IPO at $17/Sh

UNITY Biotechnology, Inc. (NASDAQ: UBX) today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $17.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by UNITY. The Company has also granted the underwriters a 30-day option to purchase from the Company an additional 750,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions. UNITY’s common stock has been approved for listing on The Nasdaq Global Select Market and is expected to begin trading under the ticker symbol “UBX” on May 3, 2018. The offering is expected to close on May 7, 2018, subject to customary closing conditions.

Goldman Sachs & Co. LLC, Morgan Stanley and Citigroup acted as joint book-running managers for the offering. Mizuho Securities acted as a lead manager for the offering.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• China chipmaker YMTC files for $4.9 billion IPO
• SpaceX shares fall as second lockup period ends